Publications by authors named "Rudolf Markstein"

Claim this Profile
A
Antiglaucoma drug GLC756 and its effect on cellular cAMP and tumor necrosis factor alpha release in vitro of activated human monocytic leukemia cells.
Ulrich W Laengle, Rudolf Markstein, Cecile Cazaubon, Danielle Roman

Jpn J Ophthalmol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of latanoprost, timolol and GLC756, a novel dopamine D(2) agonist and D(1) antagonist on LTC(4) release after rat mast cell activation.
Ulrich W Laengle, Rudolf Markstein, Dominique Pralet, Wolfgang Seewald, Danielle Roman

Clin Exp Ophthalmol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells.
Ulrich Wilhelm Laengle, Rudolf Markstein, Dominique Pralet, Wolfgang Seewald, Danielle Roman

Exp Eye Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLC756 decreases TNF-alpha via an alpha2 and beta2 adrenoceptor related mechanism.
Ulrich W Laengle, Anne U Trendelenburg, Rudolf Markstein, Vicente Nogues, Anne Provencher-Bollinger

Exp Eye Res· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of antiglaucoma drugs timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist, on endotoxin-induced-uveitis in rats.
Ulrich Wilhelm Laengle, Rudolf Markstein, Verena Schneider, Brigitte Greiner, Danielle Roman

Exp Eye Res· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis